Time spent in hypoglycemia is comparable when the same amount of exercise is performed 5 or 2 days weekly: a randomized crossover study in people with type 1 diabetes
- PMID: 33509935
- PMCID: PMC7845672
- DOI: 10.1136/bmjdrc-2020-001919
Time spent in hypoglycemia is comparable when the same amount of exercise is performed 5 or 2 days weekly: a randomized crossover study in people with type 1 diabetes
Abstract
Introduction: People with type 1 diabetes are recommended to exercise regularly. However, limited evidence exists on how frequency and duration of exercise affect the risk of hypoglycemia. The study aimed to compare the percentage of time spent in hypoglycemia between two 5-day periods with different frequency and duration of physical activity.
Research design and methods: In this outpatient randomized crossover study, 26 participants aged 18-65 years with type 1 diabetes for ≥2 years and insulin pump use for ≥1 year were included. After a 7-day observation period, participants completed two 5-day intervention periods separated by a washout period of at least 14 days. One period included five exercise sessions on 5 consecutive days (5S), each consisting of 4 min of resistance training and 30 min of aerobic exercise. Another period included two exercise sessions on 2 days with at least 2 days in between (2S), each consisting of 10 min of resistance training and 75 min of aerobic exercise. During each period, participants performed in total 150 min of aerobic exercise and 20 min of resistance training and wore continuous glucose monitors (Dexcom G6) and accelerometers (ActiGraph wGT3X-BT).
Results: Twenty insulin pump-treated adults (10 women) with type 1 diabetes completed the study. The baseline median (range) age was 48 (24-64) years, glycated hemoglobin 55 (44-66) mmol/mol, diabetes duration 24 (8-57) years, and body mass index 28.4 (22.3-35.8) kg/m2. No differences were observed between 5S and 2S in the percentage (mean±SD) of time spent below 3.9 mmol/L (3.5%±2.8% vs 4.5%±4.2%, p=0.28), time spent in 3.9-10.0 mmol/L (65.3%±15.0% vs 68.5%±13.6%, p=0.31), time spent above 10.0 mmol/L (31.2%±16.4% vs 27.3%±14.5%, p=0.15), mean glucose (8.7±1.3 mmol/L vs 8.5±1.2 mmol/L, p=0.33) and glycemic variability (35.8%±5.3% vs 35.8%±6.6%, p=0.97).
Conclusions: Time spent in hypoglycemia was comparable between the two 5-day periods with different duration and frequency of physical activity.
Trial registration number: NCT04089462.
Keywords: diabetes mellitus; exercise; hypoglycemia; type 1.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: IIKS has received speaker grants from Roche Diabetes Care and Rubin Medical. SS has served on the continuous glucose monitoring advisory board of Roche Diabetes Care. KN serves as adviser for Medtronic, Abbott and Novo Nordisk A/S, owns shares in Novo Nordisk A/S, has received research grants from Novo Nordisk A/S, Zealand Pharma, Medtronic and Roche Diabetes Care, and has received fees for speaking from Medtronic, Roche Diabetes Care, Rubin Medical, Sanofi, Novo Nordisk A/S, Zealand Pharma and Dexcom. AGR declares no duality of interest associated with his contribution to this manuscript.
Figures
Similar articles
-
Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.Lancet Diabetes Endocrinol. 2020 Jun;8(6):511-523. doi: 10.1016/S2213-8587(20)30114-5. Lancet Diabetes Endocrinol. 2020. PMID: 32445738 Clinical Trial.
-
Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: A randomized crossover trial.Diabetes Metab. 2019 Jun;45(3):294-300. doi: 10.1016/j.diabet.2018.08.002. Epub 2018 Aug 27. Diabetes Metab. 2019. PMID: 30165156 Clinical Trial.
-
No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study.Diabetologia. 2023 Jun;66(6):1035-1044. doi: 10.1007/s00125-023-05893-9. Epub 2023 Mar 7. Diabetologia. 2023. PMID: 36879098 Free PMC article. Clinical Trial.
-
Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial.Diabetes Obes Metab. 2019 Feb;21(2):349-356. doi: 10.1111/dom.13534. Epub 2018 Oct 14. Diabetes Obes Metab. 2019. PMID: 30221457 Free PMC article. Clinical Trial.
-
Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes.Can J Diabetes. 2019 Aug;43(6):406-414.e1. doi: 10.1016/j.jcjd.2018.08.193. Epub 2018 Aug 30. Can J Diabetes. 2019. PMID: 30414785 Free PMC article. Clinical Trial.
Cited by
-
Physical Activity, Dietary Patterns, and Glycemic Management in Active Individuals with Type 1 Diabetes: An Online Survey.Int J Environ Res Public Health. 2021 Sep 3;18(17):9332. doi: 10.3390/ijerph18179332. Int J Environ Res Public Health. 2021. PMID: 34501920 Free PMC article.
-
Where to Start? Physical Assessment, Readiness, and Exercise Recommendations for People With Type 1 or Type 2 Diabetes.Diabetes Spectr. 2023 May;36(2):105-113. doi: 10.2337/dsi22-0016. Epub 2023 May 15. Diabetes Spectr. 2023. PMID: 37193205 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous